To evaluate the efficacy and safety of mirabegron in children and adolescents (aged 3 to Click to show full abstract
To evaluate the efficacy and safety of mirabegron in children and adolescents (aged 3 to <18 years) with neurogenic detrusor overactivity (NDO) using clean intermittent catheterization.
Keywords:
efficacy safety;
neurogenic detrusor;
safety mirabegron;
children adolescents;
detrusor overactivity;
mirabegron children
Journal Title: Neurourology and Urodynamics
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Neurourology and Urodynamics
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!